ACET
ACET
NASDAQ · Biotechnology

Adicet Bio Inc

$8.64
+0.08 (+0.93%)
As of Jun 30, 10:37 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +68.3% upside
Low Target $12.76
Average Target $14.54
High Target $24.66
Current Price $8.64
Current
$8.64
Target
$14.54
$12.76 $14.54 avg $24.66
Scenario Analysis
Bear Case
$12.76
47.7%
Low target
Base Case
$14.54
+68.3%
Avg target
Bull Case
$24.66
+185.4%
High target
Risk/Reward
3.9x
Highly favorable
Price in Context
52-Week High
$17.44
-50.5% from high
52-Week Low
$6.01
+43.8% from low
Target vs 52W High
$14.54
-16.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.4%